Device closure of secundum atrial septal defect's and the risk of cardiac erosion

被引：25

作者：

Thomson J.D.R. ^{[1
]}

Qureshi S.A. ^{[2
]}

机构：

[1] Department of Congenital Cardiology, Leeds General Infirmary, E Floor, Jubilee Wing, Leeds

[2] Department of Paediatric Cardiology, Evelina London Childrens Hospital, Westminster Bridge Road, London

来源：

Echo Research & Practice | 2015年 / 2卷 / 4期

关键词：

Atrium; Congenital heart defects; Congenital heart disease; Device closure;

D O I：

10.1530/ERP-15-0023

中图分类号：

学科分类号：

摘要：

Cardiac erosion related to transcatheter atrial septal defect closure devices is of increasing concern. Erosion is reported to have occurred with most of currently available occluder devices. Perhaps due to the very large number of implants worldwide, the Amplatzer (St Jude) occluder is associated with the majority of cardiac erosion events reported in the literature. Best current estimates of the incidence of erosion with the St Jude device are between one and three cases per 1000 implants. Most events occur early after implantation and it is rare, although not unheard of, for events to occur after a year following device insertion. It is important that those involved with closure programmes are vigilant for the problem, because device-related erosion is associated with a significant mortality risk. Despite considerable debate, the risk factors (either patient or device) for erosion remain unclear and require further investigation. Currently available data sets have focussed largely on erosion cohorts and are unable to place these cases in appropriate context with non-erosion closure cases. What is certain is that programmes implanting these devices must take care to implant appropriately sized devices and have in place plans to ensure that patients are both well informed and can access help and advice in the event of developing symptoms. © 2015 The authors.

引用

页码：R73 / R78

页数：5

共 19 条

[1]

King T.D., Thompson S.L., Steiner C., Mills N.L., Secundum atrial septal defect. Nonoperative closure during cardiac catheterization, Journal of the American Medical Association, 235, pp. 2506-2509, (1976)

[2]

Aggoun Y., Gallet B., Acar P., Pulik M., Czitrom D., Lagier A., Laborde F., Perforation of the aorta after percutaneous closure of an atrial septal defect with an Amplatz prosthesis presenting with acute severe hemolysis, Archives des Maladies du Coeur et des Vaisseaux, 95, pp. 479-482, (2002)

[3]

Chun D.S., Turrentine M.W., Moustapha A., Hoyer M.H., Development of aorta-to-right atrial fistula following closure of secundum atrial septal defect using the Amplatzer septal occluder, Catheterization and Cardiovascular Interventions, 58, pp. 246-251, (2003)

[4]

Divekar A., Gaamangwe T., Shaikh N., Raabe M., Ducas J., Cardiac perforation after device closure of atrial septal defects with the Amplatzer septal occluder, Journal of the American College of Cardiology, 45, pp. 1213-1218, (2005)

[5]

Amin Z., Hijazi Z.M., Bass J.L., Cheatham J.P., Hellenbrand W.E., Kleinman C.S., Erosion of Amplatzer septal occluder device after closure of secundum atrial septal defects: Review of registry of complications and recommendations to minimize future risk, Catheterization and Cardiovascular Interventions, 63, pp. 496-502, (2004)

[6]

Di Bardino D.J., McElhinney D.B., Kaza A.K., Mayer J.E., Analysis of the U.S. Food and Drug Administration Manufacturer and User Facility Device Experience database for adverse events involving Amplatzer septal occluder devices and comparison with the Society of Thoracic Surgery congenital cardiac surgery database, Journal of Thoracic and Cardiovascular Surgery, 137, pp. 1334-1341, (2009)

[7]

Diab K., Kenny D., Hijazi Z.M., Erosions erosions and erosions! Device closure of atrial septal defects: How safe is safe?, Catheterization and Cardiovascular Interventions, 80, pp. 168-174, (2012)

[8]

Beg K., Latson L.A., Pettersson G., Wallace L., Qureshi A.M., Aorta-to-left atrial fistula developing after surgical removal of an atrial septal occlusion device eight years after original implantationN, World Journal for Pediatric & Congenital Heart Surgery, 6, pp. 320-323, (2015)

[9]

Circulatory System Advisory Panel Meeting-Transcatheter ASD Occluders: Clinical Update and Review of Events [Pdf], (2012)

[10]

Moore J., Hegde S., El-Said H., Beekman R., Benson L., Bergersen L., Holzer R., Jenkins K., Ringel R., Rome J., Transcatheter device closure of atrial septal defects. A safety review, JACC, 5, pp. 433-442, (2013)

← 1 2 →